Engineered Trimeric CD70 Proteins and Uses Thereof, Fred Hutchinson Cancer Center, EP4041410A2
Summary
European Patent application EP4041410A2 filed by Fred Hutchinson Cancer Center for engineered trimeric CD70 proteins and uses thereof, published April 15, 2026. The application covers engineered trimeric CD70 proteins with therapeutic applications including anticancer uses, classified under IPC A61P 35/00 and C07K 16/40. The application designates 31 European Patent Convention contracting states for potential patent protection.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.
What changed
European Patent application EP4041410A2 filed by Fred Hutchinson Cancer Center was published by the EPO on April 15, 2026, covering engineered trimeric CD70 proteins and their therapeutic uses.
For biotechnology and pharmaceutical entities working with CD70 targeting technologies, this publication constitutes prior art and may affect freedom-to-operate assessments. Competitors developing similar immunotherapy approaches should monitor the prosecution of this application across designated EPC states.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ENGINEERED TRIMERIC CD70 PROTEINS AND USES THEREOF
Publication EP4041410A2 Kind: A2 Apr 15, 2026
Applicants
Fred Hutchinson Cancer Center
Inventors
JAEGER, Carla, A., CORRENTI, Colin, E., RIDDELL, Stanley, R.
IPC Classifications
A61P 35/00 20060101AFI20231102BHEP C07K 16/40 20060101ALI20231102BHEP C12N 15/62 20060101ALI20231102BHEP C07K 16/46 20060101ALI20231102BHEP C07K 14/54 20060101ALI20231102BHEP A61P 31/00 20060101ALI20231102BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.